United States · FDA National Drug Code directory
Omeprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62175-136_e786b865-dc62-4018-9cb1-7056b7ca2cde
- Product NDC
- 62175-136
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- omeprazole
- Labeler
- Lannett Company, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090123
- Source listing expiry
- 20261231
Source-listed ingredients
- OMEPRAZOLE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62175-136-32) · 62175-136-32
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62175-136-37) · 62175-136-37
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62175-136-43) · 62175-136-43
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62175-136-46) · 62175-136-46
- 36000 CAPSULE, DELAYED RELEASE in 1 DRUM (62175-136-49) · 62175-136-49
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →